Aetiology of HAP

Causes of hospital-acquired pneumonia (HAP) include:

  • Streptococcus pneumoniaeSuaya, 2021 – part of the usual respiratory flora
  • gram-negative bacteria (eg nonmultidrug-resistant [non-MDR] Enterobacterales) – prolonged hospitalisation is a risk factor for colonisation
  • more resistant bacteria – recent broad-spectrum antibiotic therapy is a risk factorChang, 2021Costa, 2019Kalil, 2016Torres, 2017
    • resistant gram-negative bacteria (eg multidrug-resistant [MDR] Enterobacterales, Pseudomonas aeruginosa, Acinetobacter species)
    • methicillin-resistant Staphylococcus aureus [MRSA] – in many Australian hospitals, nosocomial MRSA pneumonia is uncommon
  • respiratory viruses – can be acquired from other patients, visitors or staffAbbas, 2021
    • severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    • influenza
    • respiratory syncytial virus (RSV)
  • atypical pathogens1 – much less common cause of HAP than community-acquired pneumonia (CAP)Hagel, 2019
    • Legionella species – rare, but can be acquired from a contaminated environmental reservoir in the hospital
    • Chlamydophila (Chlamydia) pneumoniae
    • Mycoplasma pneumoniae
  • fungal pathogens – rare cause of HAP; most often in patients with immune compromise
    • Aspergillus species
    • Pneumocystis jirovecii.

Although Candida species2 can colonise the respiratory tract of patients in hospital, they rarely, if ever, cause HAP.

Children with chronic suppurative lung disease (eg bronchiectasis, cystic fibrosis) may be colonised with P. aeruginosa. For information about managing HAP in children with bronchiectasis, see Management of low- to moderate-severity HAP in patients with COPD and bronchiectasis. For management of HAP in children with cystic fibrosis, see Airway infection and antibiotic therapy in cystic fibrosis.

For aetiology of ventilator-associated pneumonia (VAP), see Ventilator-associated pneumonia.

1 There is no universally accepted definition of atypical pathogens. The term is used to describe bacteria that are intrinsically resistant to beta lactams and not identifiable by standard blood or sputum culturesGarin 2022.Return
2 Some yeast species that were previously considered Candida species have been reclassified and are now considered candida-like and may be reported with a new name (eg Nakaseomyces glabratus, Pichia kudriavzevii)Borman, 2021. For a list of common Candida and related species and (if applicable) revised species names, see Common Candida and related species, and changes to nomenclature.Return